Country Club Trust Company n.a. acquired a new position in shares of AmerisourceBergen Corp. (NYSE:ABC) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,420 shares of the company’s stock, valued at approximately $202,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of ABC. Summit X LLC grew its position in AmerisourceBergen by 3.7% in the fourth quarter. Summit X LLC now owns 4,711 shares of the company’s stock valued at $400,000 after acquiring an additional 168 shares during the last quarter. Global Retirement Partners LLC lifted its holdings in shares of AmerisourceBergen by 7.4% in the fourth quarter. Global Retirement Partners LLC now owns 5,196 shares of the company’s stock worth $442,000 after acquiring an additional 358 shares during the last quarter. Convergence Investment Partners LLC lifted its holdings in shares of AmerisourceBergen by 21.3% in the fourth quarter. Convergence Investment Partners LLC now owns 35,307 shares of the company’s stock worth $3,002,000 after acquiring an additional 6,196 shares during the last quarter. Patriot Financial Group Insurance Agency LLC lifted its holdings in shares of AmerisourceBergen by 60.0% in the fourth quarter. Patriot Financial Group Insurance Agency LLC now owns 432 shares of the company’s stock worth $37,000 after acquiring an additional 162 shares during the last quarter. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its stake in shares of AmerisourceBergen by 392.9% in the 4th quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 345 shares of the company’s stock valued at $29,000 after purchasing an additional 275 shares in the last quarter. 66.72% of the stock is owned by institutional investors and hedge funds.
AmerisourceBergen stock opened at $91.16 on Friday. The stock has a 50-day moving average price of $86.67 and a two-hundred day moving average price of $86.14. AmerisourceBergen Corp. has a 12 month low of $70.55 and a 12 month high of $94.75. The company has a market capitalization of $18.95 billion, a PE ratio of 22.62, a P/E/G ratio of 1.65 and a beta of 0.96. The company has a current ratio of 0.95, a quick ratio of 0.58 and a debt-to-equity ratio of 1.45.
AmerisourceBergen (NYSE:ABC) last released its quarterly earnings results on Thursday, November 7th. The company reported $1.61 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.58 by $0.03. AmerisourceBergen had a return on equity of 48.84% and a net margin of 0.48%. The company had revenue of $45.64 billion for the quarter, compared to analysts’ expectations of $45.15 billion. During the same period in the previous year, the business posted $1.45 earnings per share. The business’s quarterly revenue was up 5.4% compared to the same quarter last year. As a group, analysts predict that AmerisourceBergen Corp. will post 7.53 earnings per share for the current fiscal year.
In other AmerisourceBergen news, CEO Steven H. Collis sold 19,905 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $84.42, for a total value of $1,680,380.10. Following the completion of the transaction, the chief executive officer now directly owns 162,027 shares in the company, valued at approximately $13,678,319.34. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP John G. Chou sold 13,997 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $86.07, for a total transaction of $1,204,721.79. Over the last quarter, insiders have sold 64,724 shares of company stock worth $5,561,840. 27.80% of the stock is owned by corporate insiders.
A number of research firms recently issued reports on ABC. TheStreet upgraded shares of AmerisourceBergen from a “c+” rating to a “b-” rating in a research report on Friday, December 6th. Barclays restated a “hold” rating and issued a $100.00 target price on shares of AmerisourceBergen in a research report on Sunday, January 19th. Argus reaffirmed a “buy” rating and set a $110.00 target price on shares of AmerisourceBergen in a research note on Monday, November 18th. Finally, ValuEngine downgraded shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Friday, November 1st. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $91.50.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Featured Story: How is the discount rate different from the Federal Funds rate?
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.